|
Based on the information provided, no conclusions can be made.As reported, patient experienced post-op incision site complication.Medical affairs has assessed the patient¿s postoperative course as being serious and likely related to the study device.Review of the device history records confirmed the device was manufactured to specification.Note: this mdr report is related to a retrospective study conducted to proactively gather real-world evidence on the use and safety of the p4hb product family, including galaflex scaffold, galaflex 3d, and galaflex 3dr. all safety events from the study are adjudicated by the bd medical monitor for an independent assessment of severity and relatedness. in an abundance of caution, events for which relatedness cannot be ruled out are processed for mdr reporting.Not returned.
|
|
Per clinical trial (b)(6): on (b)(6) 2018, patient underwent bilateral revision augmentation mastopexy using a full vertical and horizontal t incision.1 piece of galaform (galaflex 3dr) was used.Concomitant procedures included bl superior capsulotomy and bl inferior capsulorrhaphy.On (b)(6) 2018, right breast incision site complication was reported.Small eschar on incision.Patient was treated with medication (topical betadine).Resolved without sequelae on (b)(6) 2018.Review by medical affairs identifies the reported incision site complication is likely related to the device and serious.
|